Cardiovascular
Stereotaxis to Present at the JMP Securities Healthcare Conference
September 24, 2010 3:31 am | by Bio-Medicine.Org | News | CommentsST. LOUIS, Sept. 24 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that executive management will present at The Fifth Annual JMP Securities Healthcare Conference on Tuesday, September 28, 2010 at 8:30 a.m. ET in New York. Dan Johnston, Chief Financial Officer, will provide an...
Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
September 23, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 23 /- Reportlinker.com announces that a new market research report is available in its catalogue: Sanofi-Aventis: PharmaVitae Profile http://www.reportlinker.com/p0201760/Sanofi-Aventis-PharmaVitae-Profile.... Introduction This analysis examines the historical and...
Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
September 23, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, Sept. 23 /- One-year data from the PARTNER clinical trial, published yesterday in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who...
Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C.
September 23, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsSAN LEANDRO, Calif., Sept. 23 /- Preclinical data of a novel therapy designed to treat drug-resistant hypertension (high blood pressure) was presented Tuesday, September 21st, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Conference in Washington, DC, by Christopher D....
Boston Scientific's TAXUS® Element™ Stent Demonstrates Strong Outcomes in Diabetic Patients
September 23, 2010 6:34 am | by Boston Scientific | News | CommentsCompany presents one-year clinical data at TCT on its platinum chromium paclitaxel-eluting coronary stent from PERSEUS trial
Contact System Has Integrated Isolation Seals
September 23, 2010 6:22 am | Bal Seal Engineering, Inc. | Product Releases | CommentsBal Seal Engineering Inc., a global provider of custom-engineered sealing, connecting, and conducting solutions, has announced plans to launch the world’s first integrated seal and electrical contact system for active implantable devices.
Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
September 22, 2010 4:32 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Sept. 22 /- Biomatrica Inc., the leader in room temperature biological sample stabilization, today announced the release of DNAgard® Blood and DNAstable® Blood. DNAgard® Blood is a new addition to the "Gard" product line for the stabilization and shipping of...
Boston Scientific Announces Clinical Data Supporting Safety and Efficacy of Platinum Chromium PROMUS Element™ Stent
September 21, 2010 12:31 pm | by Boston Scientific | News | CommentsNine-month results from PLATINUM clinical program presented at TCT
Study examines use of stent with bioabsorbable polymer
September 21, 2010 11:36 am | by EurekAlert | News | Comments(Cardiovascular Research Foundation) Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter...
New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed
September 21, 2010 11:32 am | by Bio-Medicine.Org | News | CommentsSTOCKHOLM, Sept. 21 /- More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six...
Connections at the Heart of the Matter
September 21, 2010 10:03 am | by Mark D. Halloran | Articles | CommentsEnsuring proper connection of leads into implantable cardiac devices can be challenging, especially for small start-ups whose specialty may not focus on this area. As a result, one company is offering a solution that can be completely integrated easily into a device to help satisfy the requirements of this component and enable a faster time to market.
PROMUS® Element™ Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
September 21, 2010 5:31 am | by Boston Scientific | News | CommentsNATICK, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that its PROMUS® Element™ Everolimus-Eluting Coronary Stent System has received CE Mark approval for use in patients
Facelift Healing Innovation: New Study Shows Hyperbaric Oxygen Therapy Decreases Bruising in Facelifts Patients by 35%
September 21, 2010 4:32 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 21 /- A new study released on September 20, 2010, in the Archives of Facial Plastic Surgery details a breakthrough innovation in post-op treatment for facelifts. The study, performed by renowned New York Facial Plastic and Reconstructive Surgeon Dr. Andrew Jacono...
Aethlon Medical Reestablishes Biodefense Programs
September 21, 2010 4:32 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Sept. 21 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has reestablished efforts to advance the Aethlon Hemopurifier® within U.S. Government...
Volcano Announces It Will End Distribution Agreement with Fukuda; Transition Enhances Company's Direct Selling Program in Japan
September 21, 2010 4:32 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Sept. 21 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has reached an agreement with...
Cardiac Science Introduces MTWA Module for Stress Testing
September 21, 2010 4:31 am | by Bio-Medicine.Org | News | CommentsBOTHELL, Wash., Sept. 21 /- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in automated external defibrillator ( AED ) and diagnostic cardiac monitoring devices, today announced the launch of a Microvolt T-Wave Alternans (MTWA) module that integrates with its...
InfraReDx's New LipiScan™ IVUS Coronary Imaging System to be Highlighted at TCT 2010
September 17, 2010 7:31 am | by Bio-Medicine.Org | News | CommentsBURLINGTON, Mass., Sept. 17 /- InfraReDx, Inc. , a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that its new LipiScan™ IVUS Coronary Imaging System will be highlighted during the annual Transcatheter Cardiovascular...
FDA expands approval of implants for heart failure
September 16, 2010 2:45 pm | by The Associated Press | News | CommentsThe Food and Drug Administration said Thursday it approved three implantable heart devices from Boston Scientific Corp. for a new use in treating heart failure patients.All three devices are cardiac resynchronization therapy defibrillators. The devices are implanted in the upper chest and use...
Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds
September 16, 2010 1:35 pm | by Boston Scientific | News | CommentsFDA approval is based on results from the Company's landmark MADIT-CRT trial
Gene Therapy Combats Hereditary Blood Disease
September 15, 2010 8:35 pm | by Massachusetts Institute of Technology | News | CommentsThe treatment suggests that the approach could be used to treat more common disorders.
Access Scientific Partners with Teleflex to Launch PICC WAND
September 15, 2010 11:31 am | News | CommentsAccess Scientific has partnered with Teleflex Incorporated to launch the new PICC WAND™, which enables clinicians to insert a peelable sheath for PICC or midline catheter placement using the new Accelerated Seldinger Technique(AST)
Reportlinker Adds Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
September 14, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 14 /- Reportlinker.com announces that a new market research report is available in its catalogue: Cardiovascular Surgery Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...
Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
September 14, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsNEW YORK Sept. 14 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...
Lung transplant now viable option at any age
September 13, 2010 4:36 pm | by Baylor College of Medicine | News | CommentsDue to scientific advancements, lung transplants are a reasonable option for those dealing with end-stage lung disease at any age, according to an expert at Baylor College of Medicine . "End-stage lung disease occurs when someone loses more than 70 percent of lung function as determined...
Faculty member's book profiles successful health care leaders
September 13, 2010 4:36 pm | by Arizona State University | News | CommentsASU's Jack Gilbert has co-written a book, which challenges the view that new tools, processes and knowledge are enough to deliver the highest levels of safety, quality performance, employee engagement and financial health.read more
